A Prospective Study to Compare Concomitant Boost Radiotherapy and Conventional Radiotherapy in Oral Cavity Cancer

Shekhar Anand and Prasad Sn
Additional contact information
Shekhar Anand: Resident, GSVM Medical College, India
Prasad Sn: Professor and Head, GSVM Medical College, India

Cancer Therapy & Oncology International Journal, 2019, vol. 13, issue 3, 103-108

Abstract: India accounts for the highest incidence of oral and oropharyngeal cancers. For early stages, chemoradiotherapy or surgery are equally effective. For advanced stages require multimodality treatment. Standard chemoradiotherapy requires 2Gy per fractios, 5 fractions per week for 7 weeks. Accelerated repopulation sets in the 4th week of conventional radiation. To offset this effect, concomitant boost radiotherapy may be used. This study was designed to compare prospectively conventional chemoradiotherapy with concomitant boost chemoradiotherapy.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555865.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555865.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:13:y:2019:i:3:p:103-108

DOI: 10.19080/CTOIJ.2019.13.555865

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().